Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.59 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.59 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.59 |
| ▸ | HRH1 | P35367 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | PI4KA | P42356 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29371176 | 1.00 | EHMT2 (0.59) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL476479 | 0.98 | EHMT2 (0.57) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL957295 | 0.98 | EHMT2 (0.57) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29421834 | 0.98 | EHMT2 (0.57) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3416002 | 0.98 | EHMT2 (0.57) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| Cysteamine SCHEMBL2637878 | 0.92 | EHMT2 (0.50) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| SCHEMBL1271908 | 0.89 | EHMT2 (0.55) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| SCHEMBL10802711 | 0.89 | EHMT2 (0.55) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 | |
| SCHEMBL11833495 | 0.88 | EHMT2 (0.70) | EHMT2EHMT1APOBEC3GALDH1A1MAPT | |
| SCHEMBL3991936 | 0.87 | EHMT2 (0.53) | EHMT2EHMT1APOBEC3GHRH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 885 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514962-B2 | Medical device comprising a coating for mitigation of formation and/or growth of biofilm | CYTACOAT AB (SE) | 2026-01-06 | — | — | US | claimed |
| CN-118240237-B | Nano silicon dioxide-protein conjugate and preparation method thereof | 烟台泰和新材高分子新材料研究院有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118240237-A | Nano silicon dioxide-protein conjugate and preparation method thereof | 烟台泰和新材高分子新材料研究院有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-117797275-A | Lipid-mesoporous silicon nano delivery carrier and preparation method thereof | 河南工业大学 | 2024-04-02 | — | — | CN | claimed |
| EP-3442594-B1 | BLOCK COPOLYMER FOR OVERCOMING DRUG RESISTANCE OF TUMOURS TO CHEMOTHERAPY, ITS POLYMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARATION AND USE THEREOF | USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I (CZ) | 2024-02-07 | — | — | EP | claimed |
| CN-112121174-B | Heparin nano drug carrying system for loading amino antitumor drug and preparation method thereof | 南京健友生化制药股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-112402625-B | Photosensitizer-loaded PEG (polyethylene glycol) heparin nano micelle and preparation method thereof | 健进制药有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-111875653-A | Disulfide bond-containing amphotericin B derivative and application thereof | 深圳市儿童医院 | 2020-11-03 | — | — | CN | claimed |
| CN-108503718-B | Hydroxyalkyl starch conjugate and preparation method and application thereof | 华中科技大学 | 2020-03-20 | — | — | CN | claimed |
| EP-3442594-A1 | BLOCK COPOLYMER FOR OVERCOMING DRUG RESISTANCE OF TUMOURS TO CHEMOTHERAPY, ITS POLYMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARATION AND USE THEREOF | Ustav Makromolekularni Chemie AV CR, v.v.i. (CZ) | 2019-02-20 | — | — | EP | claimed |
| WO-1998031734-A1 | COMPOSITION AND METHOD FOR REGULATING THE ADHESION OF CELLS AND BIOMOLECULES TO HYDROPHOBIC SURFACES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-07-23 | — | — | WO | claimed |
| US-5516703-A | FORMING A HYDROPHILIC SURFACE HAVING A SPECIFIC CHEMICAL REACTIVITY ON A HYDROPHOBIC SUBSTRATE | THE UNIVERSITY OF UTAH (US) | 1996-05-14 | — | — | US | claimed |
| EP-0589867-B1 | SENSING SURFACES CAPABLE OF SELECTIVE BIOMOLECULAR INTERACTIONS, TO BE USED IN BIOSENSOR SYSTEMS | PHARMACIA BIOSENSOR AB (SE) | 1996-04-10 | — | — | EP | claimed |
| EP-0445813-B1 | 7-(Diphenylmethyl)oxy-9a-methoxymitosane and the preparation and use thereof | BRISTOL MYERS SQUIBB CO (US) | 1995-08-02 | — | — | EP | claimed |
| US-5436161-A | Matrix coating for sensing surfaces capable of selective biomolecular interactions, to be used in biosensor systems | PHARMACIA BIOSENSOR AB (SE) | 1995-07-25 | — | — | US | claimed |
| US-5352798-A | Intermediates for mitomycins; antitumor agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-10-04 | — | — | US | claimed |
| EP-0589867-A1 | SENSING SURFACES CAPABLE OF SELECTIVE BIOMOLECULAR INTERACTIONS, TO BE USED IN BIOSENSOR SYSTEMS. | PHARMACIA BIOSENSOR AB (SE) | 1994-04-06 | — | — | EP | claimed |
| US-5242828-A | SENSING SURFACES CAPABLE OF SELECTIVE BIOMOLECULAR INTERACTIONS, TO BE USED IN BIOSENSOR SYSTEMS | PHARMACIA BIOSENSOR AB (SE) | 1993-09-07 | — | — | US | claimed |
| EP-0445813-A1 | 7-(Diphenylmethyl)oxy-9a-methoxymitosane and the preparation and use thereof | Bristol-Myers Squibb Company (US) | 1991-09-11 | — | — | EP | claimed |
| WO-1990005303-A1 | SENSING SURFACES CAPABLE OF SELECTIVE BIOMOLECULAR INTERACTIONS, TO BE USED IN BIOSENSOR SYSTEMS | PHARMACIA AB (SE) | 1990-05-17 | — | — | WO | claimed |